Five-year follow-up of incretin-based therapy in a patient with KCNJ11-related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction. [PDF]
Ohkuma T +4 more
europepmc +1 more source
Out of target glycemic control and severe hypoglycemia in older adults with diabetes presenting to the emergency department. [PDF]
Pihl RU +4 more
europepmc +1 more source
Understanding Diabetes Distress: A Study of Contributing Factors Among Adults With Type 2 Diabetes in Rural East Godavari, Andhra Pradesh. [PDF]
Meka RJ +4 more
europepmc +1 more source
Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis. [PDF]
Wang M, Liu T, Zhao B.
europepmc +1 more source
Objective: To examine the intersection between location of residence along the rural-urban continuum (metropolitan/urban/rural) and sulfonylurea dispensation records for the management of type 2 diabetes.
Lauren C Bresee, Scot H Simpson
exaly +2 more sources
Related searches:
Sulfonylurea receptors and mechanism of sulfonylurea action
Experimental and Clinical Endocrinology & Diabetes, 2009Binding of hypoglycemic sulfonylureas and their analogues to the sulfonylurea receptor in the beta-cell plasma membrane mediates closure of the ATP-sensitive K+-channel (KATP-channel) and thereby stimulation of insulin release. The sulfonylurea receptor is a member of the traffic ATPase family with two intracellular nucleotide binding folds.
U, Panten +2 more
openaire +2 more sources
The pharmacology of sulfonylureas
The American Journal of Medicine, 1981In this report we review the pharmacology of the hypoglycemic sulfonylurea drugs. The early work with sulfonylureas is briefly described. The pharmacokinetics of first-generation sulfonylureas, such as tolbutamide, chlorpropamide, acetohexamide and tolazamide, are described.
T G, Skillman, J M, Feldman
openaire +2 more sources
Sulfonylurea drugs such as tolbutamide have been used extensively in the treatment of patients with diabetes mellitus. The recent report of the University Group Dia betes Program (UGDP) (1) suggested an association of tolbutamide therapy with increased incidence of cardiovascular deaths.
G S, Levey, K C, Lasseter, R F, Palmer
openaire +2 more sources

